Loading
Latest filing published 12 Oct 2022 for GeneTether Therapeutics Inc., €523.
Andre Pereira Fraga Figueiredo discloses dealings in GeneTether Therapeutics Inc. to SEDI. Between 21 March 2022 and 11 October 2022, the trades on record add up to 5 filings.
No open-market sale appears; the market trades are 4 purchases worth €1,194. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The median purchase comes to €242. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 12 October 2022: an open-market purchase of €523, in GeneTether Therapeutics Inc. The median gap between a trade and its publication by SEDI is 1 day. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations